文献速递呼吸危重症与机械通气

危重症患者膈肌无力:基本机制揭示治疗机会

Diaphragm Weakness in the Critically Ill: Basic Mechanisms Reveal Therapeutic Opportunities.
PubMed 文献 · Chest · 2018-08-23

本综述聚焦危重症患者膈肌无力的细胞机制,指出机械通气和脓毒症是两大主要危险因素,二者通过相似的分子通路导致膈肌收缩力下降和肌肉质量减少,并探讨了针对这些共同通路进行干预以治疗或预防膈肌无力的潜力。

要点

  • 机械通气和脓毒症是危重症膈肌无力的两大危险因素。
  • 膈肌无力由收缩力缺陷和肌肉质量减少共同导致。
  • 机械通气和脓毒症相关的膈肌功能障碍涉及相似的分子机制。

核心结论

  • 危重症患者膈肌无力常见且与不良临床结局相关,机械通气和脓毒症通过共同的分子机制导致膈肌功能障碍,针对这些通路可能实现治疗或预防。

研究设计与样本

  • 综述,检索范围未在摘要中明确报告。

主要发现

  • 很大比例的危重症患者存在严重膈肌无力,并与不良临床结局相关。
  • 机械通气使用和脓毒症是危重症膈肌无力的两大危险因素。
  • 膈肌力量产生丧失由收缩力缺陷和膈肌肌肉质量减少共同导致。
  • 机械通气相关和脓毒症相关膈肌功能障碍涉及许多相同的分子机制。

临床怎么用

  • 关注危重症患者膈肌无力,尤其机械通气和脓毒症患者。
  • 针对共同分子通路的治疗干预可能有助于预防或治疗膈肌无力。

局限性

  • 本文为综述,未报告具体研究设计、样本量或定量数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The diaphragm is the primary muscle of inspiration. Its capacity to respond to the load imposed by pulmonary disease is a major determining factor both in the onset of ventilatory failure and in the ability to successfully separate patients from ventilator support. It has recently been established that a very large proportion of critically ill patients exhibit major weakness of the diaphragm, which is associated with poor clinical outcomes. The two greatest risk factors for the development of diaphragm weakness in critical illness are the use of mechanical ventilation and the presence of sepsis. Loss of force production by the diaphragm under these conditions is caused by a combination of defective contractility and reduced diaphragm muscle mass. Importantly, many of the same molecular mechanisms are implicated in the diaphragm dysfunction associated with both mechanical ventilation and sepsis. This review outlines the primary cellular mechanisms identified thus far at the nexus of diaphragm dysfunction associated with mechanical ventilation and/or sepsis, and explores the potential for treatment or prevention of diaphragm weakness in critically ill patients through therapeutic manipulation of these final common pathway targets.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Petrof BJ. Diaphragm Weakness in the Critically Ill: Basic Mechanisms Reveal Therapeutic Opportunities. Chest. 2018. PMID: 30144420. doi:10.1016/j.chest.2018.08.1028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。